Double Medical(SZ:002901) Sou Hu Cai Jing·2025-10-16 12:42Core Viewpoint - The stock of Dabo Medical (002901) has shown a decline in price and mixed capital flow, indicating potential volatility in investor sentiment and market performance [1][2]. Group 1: Stock Performance - As of October 16, 2025, Dabo Medical's stock closed at 54.78 yuan, down 1.33% with a turnover rate of 0.78% and a trading volume of 22,400 hands, resulting in a transaction amount of 124 million yuan [1]. - Over the past five days, the stock has experienced fluctuations, with a notable drop of 2.94% on October 15, 2025, and a previous increase of 0.77% on October 13, 2025 [2]. Group 2: Capital Flow Analysis - On October 16, 2025, the net inflow of main funds was 6.44 million yuan, accounting for 5.2% of the total transaction amount, while retail investors saw a net outflow of 11.24 million yuan, representing 9.07% of the total [1][2]. - The capital flow data indicates that institutional investors have shown interest, with one buy rating given in the last 90 days [4]. Group 3: Financial Metrics and Industry Comparison - Dabo Medical's total market value is 22.68 billion yuan, significantly higher than the industry average of 11.875 billion yuan, ranking 10th in the industry [3]. - The company reported a net profit of 244 million yuan for the first half of 2025, a year-on-year increase of 76.69%, with a gross margin of 71.01%, which is above the industry average of 51.85% [3]. - The company's return on equity (ROE) stands at 7.6%, outperforming the industry average of 1.8%, indicating strong profitability relative to its equity base [3].